T. J. Schall, “Biology of the Rantes/sis Cytokine Family”, Cytokine, vol. 3, No. 3, May 1991, pp. 165-183. |
P. M. Murphy, “The Molecular Biology of Leukocyte Chenattractant Receptors”, Annual Review of Immunology, vol. 12, 1994, pp. 593-633. |
H. Deng et al., “Identification of a major co-receptor for primary isolates of HIV-1”, Nature, vol. 381, Jun. 1996, pp. 661-666. |
R. Horuk, “Molecular properties of the chemokine receptor family”, Trends Pharm. Science, vol. 15, 1994, pp. 159-165. |
A. Ben-Baruch et al., “Monocyte Chemotactic Protein-3 (MCP3) Interacts with Multiple Leukocyte Receptors”, J. Biol. Chem., vol. 270, No. 38, Sep. 1995, pp. 22123-22128. |
K. Neote et al., “Molecular Cloning, Functional Expression, and Signaling Characteristics of a C-C Chemokine Receptor”, Cell, vol. 72, Feb. 1993, pp. 415-425. |
C. Combadiere et al., “Cloning and Functional Expression of a Human Eosinophil CC Chemokine Receptor”, J. Biol. Chem., vol. 270, No. 27, Jul. 1995, pp. 16491-16494. |
C. A. Power et al., “Molecular Cloning and Functional Expression of a Novel CC Chemokine Receptor cDNA for a Human Basophilic Line”, J. Biol. Chem., vol. 270, No. 33, Aug. 1995, pp. 19495-19500. |
M. Samson et al., “Molecular Cloning and Functional Expression of a New Human CC-Chemokine Receptor Gene”, Biochemistry, vol. 35, 1996, pp. 3362-3367. |
A. Chaudhuri et al., “Expression of the Duffy Antigen in K562 Cells,”, J. Biol. Chem., vol. 269, No. 11, Mar. 1994, pp. 7835-7838. |
H. Kita et al., “Chemokines Active on Eosinophils: Potential Roles in Allergic Inflammation”, J. Exp. Med., vol. 183, Jun. 1996, pp. 2421-2426. |
D. Smith et al., “Blocking of HIV-1 Infectivity by a Soluable, Secreted Form of the CD4 Antigen”, Science, vol. 238, 1987, pp. 1704-1707. |
J. A. Levy, “Infection by Human Immunodeficiency Virus—DC4 is not Enough”, N. Eng. J. Med., vol. 335, No. 20, Nov. 1996), pp. 1528-1530. |
T. Dragic et al., “HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR5”, Nature, vol. 381, Jun. 1996, pp. 667-673. |
L. Wu et al., “CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5”, Nature, vol. 384, Nov. 1996, pp. 179-183. |
A. Trkola et al., “CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5”, Nature, vol. 384, Nov. 1996, pp. 184-187. |
M. Samson et al., “Resistence to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 cehmokine receptor gene”, Nature, vol. 382, Aug. 1996, pp. 722-725. |
C. M. Hill et al., “Natural resistence to HIV?”, Nature, vol. 382, Aug. 1996, pp. 668-669. |
Y. Huang et al., “The Role of a mutant CCR5 allele in HIV-1 transmission and disease progression”, Nature Medicine, vol. 2, No. 11, Nov. 1996, pp. 1240-1243. |
L. Zhang et al., “HIV-1 subtype and second-receptor use”, Nature, vol. 383, Oct. 1996, p. 768. |
H. Hotoda, “Small-molecule inhibitors of HIV-1 entry via chemokine receptors”, Drugs of the Future, vol. 24, No. 12, 1999, pp. 1355-1362. |
R. Horuk et al., “Chemokine Receptor Antagonists”, Med. Res. Rev., vol. 20, No. 2, 2000, pp. 155-168. |
M. Shiraishi et al., “Discovery of Novel, Potent , and Selective Small-Molecule CCR5 Antagonists as Anti-HIV-1 Agents: Synthesis and Biological Evaluation of Anilide Derivatives with a Quanternary Ammonium Moiety”, J. Med. Chem., vol. 43, 2000, pp. 2049-2063. |